Gene Therapy for Cardiovascular Disease: A Case for Cautious Optimism

Hypertension - United States
doi 10.1161/hy1101.099483
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Cautious Optimism for Transplantation Under Trump Administration

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2017English

Access to Benznidazole for Chagas Disease in the United States—Cautious Optimism?

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2017English

Cautious Optimism for Induction Immunotherapy in Resectable Lung Cancer

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

P38 Inhibition in COPD; Cautious Optimism

Thorax
PulmonaryRespiratory Medicine
2013English

Oligonucleotide-Based Gene Therapy for Cardiovascular Disease Are Oligonucleotide Therapeutics Novel Cardiovascular Drugs

Current Drug Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2000English

Heart Rate: A Global Target for Cardiovascular Disease and Therapy Along the Cardiovascular Disease Continuum

Journal of Cardiology
Cardiovascular MedicineCardiology
2013English

Gene Therapy for Parkinson Disease(Parkinson Disease)

Japanese Journal of Neurosurgery
SurgeryNeurology
2006English

Antisense Gene Therapy for Neurodegenerative Disease?

Experimental Neurology
Developmental NeuroscienceNeurology
1997English

Gene Therapy for CNS Diseases – Krabbe Disease

BioImpacts
BiochemistryMedicineGeneticsMolecular BiologyPharmaceutical Science
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy